Literature DB >> 2292762

Effect of hydrophobic coating on the behavior of a hygroscopic aerosol powder in an environment of controlled temperature and relative humidity.

A J Hickey1, I Gonda, W J Irwin, F J Fildes.   

Abstract

Powders of uncoated disodium fluorescein (DF) and DF coated with various amounts of lauric or capric acids were generated as aerosols in an environment of controlled temperature and relative humidity. The particle size and distribution of these powders were characterized using a cascade impactor and a computerized data inversion method of analysis. Disodium fluorescein exhibited a hygroscopic growth ratio of 1.5 at a relative humidity of 97%. This growth was reduced to 1.3 by coating with 0.15 g of lauric acid or 0.8 g of capric acid per gram of DF, and was eliminated with 0.2 g of lauric acid or 0.18 g of capric acid per gram of DF. The reduction in hygroscopic growth probably reflects an inhibition of the growth rate. In the time following generation and prior to deposition in the collection device, approximately 40 s, the coated aerosol powders do not seem to reach their equilibrium droplet diameter. These studies indicate that these combinations of DF and fatty acid would result in larger equilibrium droplet diameters than that of the dye alone.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2292762     DOI: 10.1002/jps.2600791113

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

Review 1.  Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development.

Authors:  Timothy M Crowder; Jacky A Rosati; Jeffry D Schroeter; Anthony J Hickey; Ted B Martonen
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

2.  Study of hygroscopic properties of aqueous mixtures of disodium fluorescein and sodium chloride using an electrodynamic balance.

Authors:  C K Chan; C S Kwok; A H Chow
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

Review 3.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

4.  The effect of metal salts on aerosol performance of spray dried carrier-free formulations of levofloxacin.

Authors:  Ahmadreza Barazesh; Kambiz Gilani; Mohammadreza Rouini; Mohammad Ali Barghi
Journal:  Daru       Date:  2019-12-05       Impact factor: 3.117

Review 5.  Behavior of hygroscopic pharmaceutical aerosols and the influence of hydrophobic additives.

Authors:  A J Hickey; T B Martonen
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

6.  Study of the hygroscopic properties of selected pharmaceutical aerosols using single particle levitation.

Authors:  C Peng; A H Chow; C K Chan
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

7.  Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device.

Authors:  Michael Hindle; P Worth Longest
Journal:  J Pharm Pharmacol       Date:  2012-02-21       Impact factor: 3.765

8.  Effect of compression pressure on inhalation grade lactose as carrier for dry powder inhalations.

Authors:  Neha Sureshrao Raut; Swapnil Jamaiwar; Milind Janrao Umekar; Nandkishor Ramdas Kotagale
Journal:  Int J Pharm Investig       Date:  2016 Jan-Mar

9.  Moisture-Resistant Co-Spray-Dried Netilmicin with l-Leucine as Dry Powder Inhalation for the Treatment of Respiratory Infections.

Authors:  Yingtong Cui; Xuejuan Zhang; Wen Wang; Zhengwei Huang; Ziyu Zhao; Guanlin Wang; Shihao Cai; Hui Jing; Ying Huang; Xin Pan; Chuanbin Wu
Journal:  Pharmaceutics       Date:  2018-12-01       Impact factor: 6.321

Review 10.  Inhaled antibodies: Quality and performance considerations.

Authors:  Anthony James Hickey; Ian Edward Stewart
Journal:  Hum Vaccin Immunother       Date:  2021-06-30       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.